ClassID:

116876

C12Y304/21079 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Granzyme B (3.4.21.79)

Recent Application in this class:
#1
20250041337
2025-02-06

FUSION PROTEIN

#2
20240307536
2024-09-19

IMPROVED ADOPTIVE CELL TRANSFER THERAPY FOR CANCER

#3
20240285686
2024-08-29

PREPARATION AND APPLICATION OF CHIMERIC ANTIGEN RECEPTOR IMMUNE CELL CONSTRUCTED ON BASIS OF GRANZYME B

#4
20240229003
2024-07-11

CELL-TARGETED CYTOTOXIC CONSTRUCTS

#5
20220267752
2022-08-25

Cell-targeted cytotoxic constructs

#6
20220033464
2022-02-03

METHODS AND COMPOSITONS FOR MODULATIONS OF IMMUNE RESPONSE

#7
20210324360
2021-10-21

CYTOTOXIC MOLECULES RESPONSIVE TO INTRACELLULAR LIGANDS FOR SELECTIVE T CELL MEDIATED KILLING

#8
20210238249
2021-08-05

MODIFIED MITOCHONDRIA AND USE THEREOF

#9
20200237860
2020-07-30

Hsp70 based combination therapy

#10
20190105378
2019-04-11

SELECTIVE CELL-DEATH-INDUCING BINARY ENZYME SYSTEM

#11
20190060236
2019-02-28

Drug delivery means

#12
20170368084
2017-12-28

Method for enhancing immunity using ginsenoside F1 as an active ingredient

#13
20170362582
2017-12-21

Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing

#14
20170260517
2017-09-14

Cell-targeted cytotoxic constructs

#15
20170253650
2017-09-07

Anti-parasitic complexes

#16
20170182096
2017-06-29

LYMPHOCYTE MEDIATED DELIVERY OF PROTEINS

#17
20170051269
2017-02-23

GRANZYME B PROTEASE VARIANTS

#18
20160038573
2016-02-11

SELECTIVE CELL-DEATH-INDUCING BINARY ENZYME SYSTEM

#19
20150352047
2015-12-10

Drug delivery means

#20
20150329847
2015-11-19

Fusion protein comprising granzyme B and use thereof

#21
20070225264
2007-09-27

Drug delivery means

#22
20060024289
2006-02-02

Cleavage of VEGF and VEGF receptor by wild-type and mutant proteases